China: Beijing Courts Issued Consequential Judgments On Life-Science Patents

Last Updated: 14 August 2017
Article by David Huang

The Beijing Higher People's Court (BHPC) and Beijing Intellectual Property Court (BIPC) recently issued their judgments in a number of high-profile validity cases in the life science area. The courts' reasoning in the judgments, unless negated in future appeal or retrial proceedings, will have general consequence beyond the specific cases.

Impact of a prior-art reference on the inventiveness of a Swiss-type claim

In this case, BIPC ruled that a mere statement in a reference like "the drug has shown exciting preliminary result in treating a disease" is enough to undermine the inventiveness of a Swiss-type claim, and there is no further need for the reference to provide detailed experimental/clinical data to convince persons in the art that the drug indeed has the therapeutic effect or has the potential.

Once the judgment was issued, the court's reasoning has drawn criticisms for its apparent tension with China's emphasis on such experimental/clinical data when disclosure sufficiency of the specification is in dispute.

The patent in dispute is Novartis's patent No. 01817895.2, and its only claim is a Swiss-type one.

The judgment also touches on another interesting procedural issue on when an argument developed by the challenger during the proceedings or a line of reasoning adopted by the Patent Reexamination Board in its final decision should be regarded as going beyond the original ways of combination raised by the challenger (in which case the argument should be rejected or the line of reasoning should be nullified).

Novartis likely has appealed the Beijing Higher People's Court as of the date of this update.

Closest prior art against an "invention by selection"

This case relates to the methodology to select the "closest prior art" for the purpose of evaluating whether an invention be selection has the required unexpected result/effect and thus has inventiveness.

An invention by selection refers to one seeking protection for one or more specific instances, a smaller subset or a narrower range selected from a larger group, set or range already known in the art. One of the conditions for such an invention to have the required inventiveness is that it produces unexpected result/effect over the prior art. And the first step to evaluate whether the result/effect it produces is unexpected or not is to determine the closest prior art against which to make the comparison.

Usually, the closest prior art for such comparison is one with the typical characteristics within the original group, set or range. In this case, however, BHPC ruled that the closest prior art can be something outside the original group, set or range if evidence shows that the selected art is comparable to ordinary instances within the original group set or range.

The patent in dispute is 01815108.6 co-owned by Daiichi-Sankyo. The specific claims at the focus of the dispute seek protection of a hydrochloride and maleate of Prasugrel, i.e. specific instances of the larger group/concept of "pharmaceutically acceptable salts of Prasugrel".

In its judgment, BHPC agrees with the patent owner to compare the result/effect of hydrochloride and maleate of Prasugrel against free alkali of Prasugrel on the grounds that (1) the overall prior art is short of evidence on the result/effect of other specific examples of pharmaceutically acceptable salts of Prasugrel, and (2) from evidence on record, persons in the art have the reason to believe that free alkali of Prasugrel is comparable to pharmaceutically acceptable salts of Prasugrel.

Specification's central role in claim construction

In this case, BHPC reiterates the position that the specification of a patent is the primary dictionary and basis for construction of the claims, and this is so even if a term in dispute has a popular meaning in the art (i.e. the inventors have the right to give their own definition for such a term in the specification). Meanwhile, the court also held, if the definition given in the specification is vague or ambiguous (e.g. for poor drafting quality), the court can use extrinsic sources for the construction of the term (e.g. an industrial dictionary that gives the commonly accepted meaning of the term as understood in the art).

The case is out of a reexamination proceeding, not an invalidation action. The application in dispute is 200680040913.X owned by DuPont. The particular term as the focus of the dispute is "E-HFC-1234ze" as recited in claim 1.

The Patent Reexamination Board in the reexamination proceeding adopted the meaning as commonly understood in the art for this term in claim construction, on the grounds that the term is so commonly used in the art and its meaning is so clear that there is no further need to read the specification for its construction.

In the judicial review, BIPBC and the BHPC both held that the board was wrong for not treating the specification as the primary source for claim construction. The courts held that even for such a term, the specification as the intrinsic evidence still has precedence over extrinsic evidence.

After reiterating the central role of the specification, BHPC further held that if the definition given in the specification is ambiguous even after all the context is considered, extrinsic evidence can be used.

The specification gives this definition for the term, "E-HFC-1234ze as used herein refers to a mixture of the isomers, E-HFC-1234ze (CAS reg no. 29118-24-9) or Z-HFC-1234ze (CAS reg. no. 29118-25-0), wherein the predominant isomer is E-HFC-1234ze". BHPC held that the "or" makes the definition unclear even after the full context is considered, and in this regard, the court was not persuaded by DuPont's argument that the "or" should be understood as "and" from the context. Based on this, BHPC agreed that the term should be construed as it is commonly understood in the art when the specification fails to give a clear definition.

Originally published March 21, 2017

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions